Radiation therapy alone for sarcoma of soft tissue

Cancer. 1985 Aug 1;56(3):475-9. doi: 10.1002/1097-0142(19850801)56:3<475::aid-cncr2820560311>3.0.co;2-s.

Abstract

Fifty-one patients have been treated with radiation therapy alone for soft tissue sarcomas, with 72.5% eligible for more than 5-year follow-up. Thirty-six of 51 patients received a radiation dose of 6400 cGy (or its equivalent) or greater. Careful attention was paid to the radiation therapy technique, using multiple angled fields, tissue-compensating wedges, immobilization devices, etc., in order to preserve a good functional result. Eleven of 51 patients are alive with no evidence of disease. The overall 5-year survival and local control rates were 25.1% and 33% respectively. For patients treated to a dose of 6400 cGy or greater, the 5-year survival and local control were 28.4% and 43.5%, respectively. Local control was better for tumors less than 5 cm diameter (87.5%) than in tumors 5 to 10 cm diameter (53%) or greater than 10 cm (30%). Only four patients in this series had a grade I tumor, and no survival difference could be detected between Grade 2 and Grade 3 tumors. This series indicates that radiation therapy alone can control tumor in a portion of patients with soft tissue sarcomas.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / radiotherapy*
  • Neoplasm Staging
  • Radiotherapy Dosage
  • Sarcoma / pathology
  • Sarcoma / radiotherapy*
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / radiotherapy*